RenovoRx IncRNXT
Price$1.55Intrinsic value$1.699% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $2M+4,495.3% YoYTTM through 30 Jun 2026
Net Income -$12.3MTTM through 30 Jun 2026
Free Cash Flow -$11.9MTTM through 30 Jun 2026

Margins

Current
Gross Margin71.0%
EBITDA Margin-584.0%
Operating Margin-1,121.1%
Net Margin-621.7%

Returns

-206.0%ROE
-138.0%ROA

Balance Sheet Health

Debt / Equity0.04x
Current Ratio5.83x
Net Debt-$6.8Mnet cash position
Cash & Equivalents$9.5M

Quality Metrics

Altman Z-Score7.40
Piotroski F-Score2 / 9
FCF Margin-604.1%
Earnings-Beat Rate0.0%

Multi-Year Trend

Revenue
'24'25
FY2025: $1.1M
Diluted EPS-$0.31TTM
'22'23'24'25
FY2025: $-0.32

Dividend

No dividend

Capital Allocation

Capex Intensity3.6%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.